A detailed history of Geode Capital Management, LLC transactions in Eyenovia, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 693,343 shares of EYEN stock, worth $450,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares
693,343
Previous 639,070 8.49%
Holding current value
$450,672
Previous $1.33 Million 48.38%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.99 - $2.37 $53,730 - $128,627
54,273 Added 8.49%
693,343 $686,000
Q4 2023

Feb 13, 2024

BUY
$1.08 - $2.08 $61,341 - $118,139
56,798 Added 9.75%
639,070 $1.33 Million
Q3 2023

Nov 13, 2023

BUY
$1.57 - $2.54 $42,065 - $68,054
26,793 Added 4.82%
582,272 $966,000
Q2 2023

Aug 11, 2023

BUY
$2.21 - $5.75 $652,860 - $1.7 Million
295,412 Added 113.59%
555,479 $1.32 Million
Q4 2022

Feb 13, 2023

BUY
$1.54 - $2.06 $9,326 - $12,475
6,056 Added 2.38%
260,067 $423,000
Q3 2022

Nov 14, 2022

BUY
$1.55 - $2.48 $127,388 - $203,821
82,186 Added 47.83%
254,011 $496,000
Q2 2022

Aug 12, 2022

BUY
$1.71 - $3.26 $16,527 - $31,507
9,665 Added 5.96%
171,825 $335,000
Q3 2021

Nov 12, 2021

BUY
$3.97 - $5.64 $13,557 - $19,260
3,415 Added 2.15%
162,160 $794,000
Q2 2021

Aug 13, 2021

BUY
$4.36 - $5.75 $86,245 - $113,740
19,781 Added 14.23%
158,745 $787,000
Q1 2021

May 12, 2021

BUY
$5.11 - $7.41 $170,806 - $247,686
33,426 Added 31.67%
138,964 $710,000
Q4 2020

Feb 12, 2021

BUY
$3.11 - $6.06 $89,085 - $173,588
28,645 Added 37.25%
105,538 $639,000
Q2 2020

Aug 13, 2020

BUY
$2.6 - $3.81 $5,600 - $8,206
2,154 Added 2.88%
76,893 $218,000
Q4 2019

Feb 13, 2020

BUY
$2.67 - $4.48 $2,613 - $4,385
979 Added 1.33%
74,739 $334,000
Q2 2019

Aug 14, 2019

BUY
$4.08 - $6.87 $16,071 - $27,060
3,939 Added 5.64%
73,760 $317,000
Q1 2019

May 14, 2019

BUY
$2.63 - $6.3 $183,629 - $439,872
69,821 New
69,821 $418,000

Others Institutions Holding EYEN

About EYENOVIA, INC.


  • Ticker EYEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,212,900
  • Market Cap $22.2M
  • Description
  • Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...
More about EYEN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.